MMED Profile
- Sector: Health Technology
- Industry: Biotechnology
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Stanley D. Glick, and Jamon Alexander Rahn in 2019 and is headquarter in Toronto, Canada.
[bbp-topic-index]
[bbp-topic-form]
Recent News
- Naturally Splendid Prepares to Receive Third Container of NATERA Plant Based Foods
- Cresco Labs Announces Proposed Offering of Subordinate Voting Shares
- Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston
- MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of DirectorsWa
- Village Farms International Announces US$135 Million Registered Direct Offering
- Namaste Technologies Announces Bought Deal Public Offering
- Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution
- Cresco Labs to Expand Into Florida Through Acquisition of Bluma Wellness Inc.
- Body and Mind Provides Corporate Update
- PeakBirch Logic Expands CBD Sales into B2B with Collaborative Agreement with Namaste Technologies
